Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease - Bakker WM; Heerspink HJL; Berger SP; Wanner C; Badve SV; Arnott C; Abrahams AC; Van Den Born JC; Van Faassen TC; Gaillard CAJM; Gelens MACJ; Górris JL; et al. (Nephrology Dialysis Transplantation, 2025)